Table 1 Baseline recipient, donor and transplant procedure characteristics

Recipient characteristics

Age (years)

53.7 ± 11.0

47.5 ± 13.5

49.7 ± 13.0

<0.001

Male gender (%)

62(67%)

115(65%)

177(66%)

0.83

Race

0.06

 Caucasian

81(87%)

150(85%)

231(86%)

 Other

12(13%)

26(15%)

38(14%)

Body Mass Index¹ (kg/m²)

0.08

 <18,5

1(1%)

5(3%)

6(2%)

 18.5-24.9

33(37%)

76(43%)

109(41%)

 25-29.9

32(35%)

70(40%)

102(38%)

 >30

24(27%)

25(14%)

49(19%)

Co-morbidities

 Hypertension

89(96%)

148(84%)

237(88%)

0.005

 Coronary artery disease

11(12%)

12(7%)

23(9%)

0.16

 Peripheral vascular disease

4(4%)

5(3%)

9(3%)

0.53

 Cerebrovascular disease

2(2%)

2(1%)

4(1%)

0.51

 Chronic lung disease

6(7%)

12(7%)

18(7%)

0.91

 Diabetes mellitus

9(10%)

12(7%)

21(8%)

0.41

Smoker

0.78

 Current

1(1%)

1(1%)

2(1%)

 Former

41(44%)

84(48%)

125(46%)

 Never

51(55%)

91(51%)

142(53%)

Etiology of ESRD

0.18

 Polycystic kidney disease

23(25%)

30(17%)

53(19%)

 Glomerulonephritis

14(15%)

33(19%)

47(17%)

 Focal sclerosing

4(4%)

6(3%)

10(4%)

 Focal and segmental proliferative

0(0%)

9(5%)

9(3%)

 IgA nephropathy

14(15%)

29(16%)

43(16%)

 Reflux nephropathy

8(9%)

19(11%)

27(10%)

 Diabetic nephropathy

7 (8%)

4 (2%)

11 (4%)

 Other

27(29%)

61(35%)

88(33%)

Renal replacement therapy

0.55

 Haemodialysis

56(60%)

97(55%)

153(57%)

 Peritoneal dialysis

27(29%)

52(30%)

79(29%)

 None

10(11%)

27(15%)

37(14%)

Previous transplants

15%

9%

11%

0.10

Length of admission (days)

8.6 ± 4.2

7.9 ± 3.8

8.2 ± 4.0

0.19

Donor characteristics

Age at transplant (years)

47.8 ± 14.6

44.0 ± 15.2

45.33 ± 13.02

0.05

Male gender (%)

42(45%)

83(47%)

125(47%)

0.76

Body Mass Index¹ (kg/m²)

0.23

 <18.5

0(0%)

8(5%)

8(3%)

 18.5-24.9

32(35%)

57(33%)

89(34%)

 25-29.9

42(46%)

76(43%)

108(45%)

 >30

17(19%)

32(19%)

49(18%)

Co-morbidities

 Hypertension

14(15%)

20(11%)

34(13%)

0.38

 Hypertension

14(15%)

20(11%)

34(13%)

0.38

 Diabetes

2(2%)

4(2%)

6(2%)

0.83

 Current

23(25%)

49(28%)

72(27%)

 Former

21(22%)

36(20%)

56(21%)

 Never

49(53%)

91(52%)

140(52%)

Donor type

0.35

 Donation after brain death

49(53%)

94(53%)

143(53%)

 Donation after cardiac death

13(14%)

15(9%)

28(10%)

 Life

31(33%)

67(38%)

98(37%)

Cause of death

0.36

 Subarachnoid haemorrhage

22(36%)

28(26%)

50(29%)

 Cardiac arrest

6(10%)

19(17%)

25(15%)

 Intracranial haemorrhage

9(14%)

15(14%)

24(14%)

 Cyclist

6(10%)

4(4%)

10(6%)

 Fall

4(6%)

5(4%)

9(5%)

 Traffic accident

2(3%)

5(4%)

7(4%)

 Hypoxia

3(5%)

4(4%)

7(4%)

 Other

10(16%)

29(27%)

39(23%)

Inotropic support

52(84%)

95(87%)

147(86%)

0.55

eGFR (mL/min/1.73 m²)

90.8 ± 22.8

94.4 ± 25.0

93.2 ± 24.3

0.25

Transplant procedure characteristics

Mismatch

3(2–5)

4(2–5)

4(2–5)

0.05

Cold ischaemic time (hours)

8.2 ± 4.5

7.6 ± 4.5

7.7 ± 4.5

0.29

Warm ischaemic time (hours)

0.6 ± 0.2

0.6 ± 0.2

0.6 ± 0.2

0.93